Home / Business and Economy / Indian-Origin CEO Reshma Kewalramani Leads Vertex Pharmaceuticals to Breakthrough Successes

Indian-Origin CEO Reshma Kewalramani Leads Vertex Pharmaceuticals to Breakthrough Successes

Summary

  • Reshma Kewalramani, an Indian-origin CEO, leads Vertex Pharmaceuticals
  • Secured approval for 5 breakthrough cystic fibrosis drugs
  • Recognized by TIME as a visionary in the biotech industry
Indian-Origin CEO Reshma Kewalramani Leads Vertex Pharmaceuticals to Breakthrough Successes

Reshma Kewalramani, an Indian-origin CEO, has risen to lead Vertex Pharmaceuticals, one of the world's top Fortune 500 biotech companies. After moving to the US at the age of 11, Kewalramani has had an extraordinary journey, culminating in her appointment as CEO of Vertex in 2020.

With a Harvard education and a background in medicine, Kewalramani has demonstrated exceptional leadership and scientific expertise. Under her guidance, Vertex has secured approval for five breakthrough drugs that treat the underlying cause of cystic fibrosis, transforming the lives of thousands of patients. Kewalramani's achievements have been widely recognized, with her inclusion in both the TIME 100 Most Influential People in the World and TIME 100 Health lists.

Kewalramani's story exemplifies the power of perseverance and the impact that visionary leaders can have in the field of modern medicine. Her leadership at Vertex Pharmaceuticals has solidified her reputation as a trailblazer in the biotech industry, inspiring others to follow in her footsteps.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

FAQ

Reshma Kewalramani is the Chief Executive Officer and President of Vertex Pharmaceuticals, a global biotech powerhouse. She joined the company in 2017 and was appointed CEO in 2020.
Under Kewalramani's leadership, Vertex Pharmaceuticals has secured approval for five breakthrough drugs that treat the underlying cause of cystic fibrosis, transforming the lives of thousands of patients.
Kewalramani has been named to both the TIME 100 Most Influential People in the World and TIME 100 Health lists, cementing her reputation as a visionary in the biotech industry.

Read more news on